Clinical Trial Update: Sirolimus as Therapeutic Approach to Uveitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating sirolimus as a therapeutic approach for uveitis has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Panuveitis
• Posterior Uveitis
• Uveitis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Johns Hopkins University | Conditions: Uveitis, Intermediate Uveitis | Phase 1 | Status: COMPLETED | Results posted: 2018-08-20